Pharmacokinetics of a Single 14C-labeled Dose of Risedronate or Alendronate Followed by Once-a-week Unlabeled Oral Dose
Clinical trial NCT00577850 · COMPLETED
Trial details
- NCT number
- NCT00577850
- Sponsor
- Warner Chilcott
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2002-11-01
- Primary completion
- 2004-02-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.